Evidence map›Paper›PMID 28949966›Full record

ArticlePloS one2017

Impact of Salmonid alphavirus infection in diploid and triploid Atlantic salmon (Salmo salar L.) fry.

Tharangani K Herath, Angela J Ashby, Nilantha S Jayasuriya, James E Bron, John F Taylor, Alexandra Adams, Randolph H Richards, Manfred Weidmann, Hugh W Ferguson, John B Taggart and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Entry receptors - the gateway to alphavirus infection.The Journal of clinical investigation · 2023
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Tharangani K HerathInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.ORCID http://orcid.org/0000-0003-3367-9294
Angela J AshbyInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Nilantha S JayasuriyaInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
James E BronInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
John F TaylorInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Alexandra AdamsInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Randolph H RichardsInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Manfred WeidmannInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Hugh W FergusonMarine Medicine Programme, School of Veterinary Medicine, St. George's University, Grenada, West Indies.
John B TaggartInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Herve MigaudInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Mark J FordyceMarine Scotland Science, Aberdeen, United Kingdom.
Kim D ThompsonInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
University of Stirling · GBMarine Scotland · GBSt. George's University · GD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With increasing interest in the use of triploid salmon in commercial aquaculture, gaining an understanding of how economically important pathogens affect triploid stocks is important. To compare the susceptibility of diploid and triploid Atlantic salmon (Salmo salar L.) to viral pathogens, fry were experimentally infected with Salmonid alphavirus sub-type 1 (SAV1), the aetiological agent of pancreas disease (PD) affecting Atlantic salmon aquaculture in Europe. Three groups of fry were exposed to the virus via different routes of infection: intraperitoneal injection (IP), bath immersion, or cohabitation (co-hab) and untreated fry were used as a control group. Mortalities commenced in the co-hab challenged diploid and triploid fish from 11 days post infection (dpi), and the experiment was terminated at 17 dpi. Both diploid and triploid IP challenged groups had similar levels of cumulative mortality at the end of the experimental period (41.1% and 38.9% respectively), and these were significantly higher (p < 0.01) than for the other challenge routes. A TaqMan-based quantitative PCR was used to assess SAV load in the heart, a main target organ of the virus, and also liver, which does not normally display any pathological changes during clinical infections, but exhibited severe degenerative lesions in the present study. The median viral RNA copy number was higher in diploid fish compared to triploid fish in both the heart and the liver of all three challenged groups. However, a significant statistical difference (p < 0.05) was only apparent in the liver of the co-hab groups. Diploid fry also displayed significantly higher levels of pancreatic and myocardial degeneration than triploids. This study showed that both diploid and triploid fry are susceptible to experimental SAV1 infection. The lower virus load seen in the triploids compared to the diploids may possibly be related to differences in cell metabolism between the two groups, however, further investigation is necessary to confirm this and also to assess the outcome of PD outbreaks in other developmental stages of the fish when maintained in commercial production systems.

Indexed as

DiploidyTriploidyAlphavirusAlphavirus InfectionsAnimalsAquacultureKidneyLiverMuscle, SkeletalMyocardiumPancreasReverse Transcriptase Polymerase Chain ReactionRNA, ViralSalmo salarViral LoadRNA, Viral

Identifiers

PMID28949966
PMCPMC5614425
OpenAlexW2667009088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.